Details for Patent: 8,697,860
✉ Email this page to a colleague
Which drugs does patent 8,697,860 protect, and when does it expire?
Patent 8,697,860 protects TEGSEDI and is included in one NDA.
This patent has thirty-three patent family members in twenty-four countries.
Summary for Patent: 8,697,860
Title: | Diagnosis and treatment of disease |
Abstract: | Provided herein are methods, compounds, and compositions for reducing expression of transthyretin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate transthyretin amyloidosis, or a symptom thereof. |
Inventor(s): | Monia; Brett P. (Encinitas, CA), Freier; Susan M. (San Diego, CA), Siwkowski; Andrew M. (Carlsbad, CA), Guo; Shuling (Carlsbad, CA) |
Assignee: | Isis Pharmaceuticals, Inc. (Carlsbad, CA) |
Application Number: | 13/944,786 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; |
Drugs Protected by US Patent 8,697,860
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Akcea Theraps | TEGSEDI | inotersen sodium | SOLUTION;SUBCUTANEOUS | 211172-001 | Oct 5, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,697,860
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Brazil | 112012027547 | ⤷ Try a Trial | |||
Canada | 2797792 | ⤷ Try a Trial | |||
Canada | 2994063 | ⤷ Try a Trial | |||
China | 103038345 | ⤷ Try a Trial | |||
Cyprus | 1119070 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |